Accéder au contenu
Merck

FAM122A, a new endogenous inhibitor of protein phosphatase 2A.

Oncotarget (2016-09-03)
Li Fan, Man-Hua Liu, Meng Guo, Chuan-Xi Hu, Zhao-Wen Yan, Jing Chen, Guo-Qiang Chen, Ying Huang
RÉSUMÉ

The regulation of the ubiquitously expressed protein phosphatase 2A (PP2A) is essential for various cellular functions such as cell proliferation, transformation, and fate determination. In this study, we demonstrate that the highly conserved protein in mammals, designated FAM122A, directly interacts with PP2A-Aα and B55α rather than B56α subunits, and inhibits the phosphatase activity of PP2A-Aα/B55α/Cα complex. Further, FAM122A potentiates the degradation of catalytic subunit PP2A-Cα with the increased poly-ubiquitination. In agreement, FAM122A silencing inhibits while its overexpression enhances cell growth and colony-forming ability. Collectively, we identify FAM122A as a new endogenous PP2A inhibitor and its physiological and pathophysiological significances warrant to be further investigated.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-PP2A Antibody, C subunit, clone 1D6, clone 1D6, Upstate®, from mouse
Sigma-Aldrich
Anti-PP2A Antibody, A subunit, Upstate®, from rabbit
Sigma-Aldrich
′, from rabbit
Sigma-Aldrich
Anti-PP2A Antibody, B subunit, clone 2G9, ascites fluid, clone 2G9, Upstate®